Patrick Dasoberi was diagnosed with Type 2 Diabetes at the age of 30. For ten years, his condition progressed β and the medical response to that progression was, each time, the same: a higher dose, a stronger medication, a new tablet added to the morning routine. By December 2025, he was on the maximum prescribed dose of Galvus Met 50/1000 and his fasting blood glucose was reading 24 mmol/L.
Then he had two blackouts in a single day. His doctor looked at his file, looked at his readings, and said the words that changed everything: βThere is nothing more I can prescribe.β
What happened in the four months that followed is the subject of this case study. It is documented. It is verified. And it is β in the view of Freedom Protocol's clinical team β replicable by anyone willing to follow the protocol with the same rigour Patrick brought to it.
HbA1c reduction in 63 days with zero medication
Weight lost over four months
Net monthly saving
Time to achieve 7.2% HbA1c
Important medical notice
This case study documents the personal experience of Patrick Dasoberi under clinical supervision. It is not medical advice and should not be treated as such. Never stop, reduce, or adjust your diabetes medication without first consulting your qualified healthcare provider. Type 2 Diabetes management must be individualised and supervised by a licensed clinician. Individual results vary. Freedom Protocol is a clinically supervised fellowship, not a medical practice.
Clinical results
Patrick Dasoberi's HbA1c fell 2.8 points β from above 10% to 7.2% β in 63 days without any diabetes medication. His fasting blood glucose, which had been reading 24 mmol/L on maximum-dose Galvus Met, now reads consistently between 6.4 and 7.8 mmol/L. These are the documented numbers. Every reading is recorded. Every claim is verifiable.
| Metric | Before Freedom Protocol | After 4 months |
|---|---|---|
| HbA1c | Above 10% | 7.2% β achieved on Day 63 |
| Fasting blood glucose (morning) | 24 mmol/L | 6.4β7.8 mmol/L (consistent) |
| Evening blood glucose | ~14 mmol/L on max medication | 5.7β6.8 mmol/L |
| Diabetes medication | Galvus Met 50/1000 (maximum dose) | NONE β stopped Day 1 |
| Weight | 105 kg (BMI 35.5 β Obese Class II) | 95 kg (BMI 32.1) β 10 kg lost |
| Energy level | 3 out of 10 | 8 out of 10 |
| Sleep quality | Poor β waking unrefreshed | Deep β waking genuinely refreshed |
| Monthly healthcare cost | GHβ΅ 930 on medication and tests | GHβ΅ 100 (Freedom Protocol) |
| Duration of diabetes | 10 years of progressive disease | In active clinical reversal |
Patient profile
Who Patrick is
Patrick Dasoberi is the founder of Freedom Protocol. He has spent years studying metabolic health, studying the clinical literature on Type 2 Diabetes reversal, designing the protocols, and building the technology platform. He understood β intellectually β exactly what the evidence said about lifestyle intervention and HbA1c reduction. He knew what intermittent fasting did to insulin sensitivity. He knew what low-carbohydrate diets did to postprandial glucose spikes.
He also knew, personally and viscerally, how difficult it was to actually do any of it. Because for ten years, despite knowing all of this, he had been unable to reverse his own disease.
βI designed Freedom Protocol. I committed to following it myself as the first patient. I would build the proof on my own body.β
Patrick was diagnosed with Type 2 Diabetes at 30. His doctor found his fasting blood glucose at 30 mmol/L β a level that, in most clinical settings, would prompt immediate hospitalisation. He was placed on medication. The medication worked β partially. His numbers came down. But they never came down enough. And over the years, the medication was increased, and then increased again, until he reached the maximum dose his doctor could legally prescribe.
His father had Type 2 Diabetes. His uncles have Type 2 Diabetes. The disease runs through his family like a thread β a thread that Patrick decided, in December 2025, to finally cut.
What came before
Galvus Met 50/1000 is a combination drug β metformin and vildagliptin β prescribed for Type 2 Diabetes when single-agent therapy is insufficient. The maximum dose is a twice-daily regimen. That is what Patrick was on. Every morning. Every evening. Maximum dose. And still β a fasting blood glucose of 24 mmol/L. Still β an HbA1c above 10%.
The medication was doing something. His numbers without medication, in the early years, had been worse. But the pharmaceutical ceiling had been reached. There was no higher dose. There was no stronger version of this drug that his doctor could add. The disease had outpaced the medicine.
The moment everything almost ended
On a morning in late November 2025, Patrick Dasoberi lost consciousness. He came around, called it a bad morning, and went on with his day. That afternoon, he lost consciousness again.
Two blackouts in a single day. He went to his doctor. His doctor reviewed his readings β 24 mmol/L that morning, consistent with every morning for months β reviewed his medication, reviewed his file, and said the words that Patrick has not forgotten:
βThere is nothing more I can prescribe. We have reached the limit of what medication can do for you. What happens from here depends entirely on what you are willing to change.β
βThat near-death experience β happening twice in a single day β was not a warning. It was a final notice.β
What he did
From Day 1 of the protocol, Patrick removed Galvus Met entirely β under clinical supervision, with daily monitoring to ensure his glucose did not drop dangerously. He adopted a 16:8 intermittent fasting schedule: eating window from 12pm to 8pm, fasting for the remaining sixteen hours. No breakfast. No morning snacking. Water, black coffee, and nothing else until noon.
The dietary shift was not a generic low-carbohydrate template imported from a European clinical trial. It was adapted specifically for the Ghanaian food environment β the ingredients available in Kasoa markets, the cost constraints, the family cooking context, the social expectations around food. Less rice, less processed carbohydrate, more protein, more vegetable matter, less sugar. Nothing that required a foreign supermarket or a specialist nutrition budget.
Every evening before bed, Patrick logged his blood glucose reading. Every morning before eating, he logged his fasting reading. The data was reviewed by his clinical team and formed the basis of weekly adjustments to his protocol. This is not a generic plan followed in isolation. It is a living protocol, adjusted in real time by people who can read the numbers and respond to them.
Scientific integrity β the discovery nobody else would report
During the protocol period, Patrick observed an anomaly. On evenings when he drank a small quantity of Guinness stout β considered by many in Ghana to be a βhealthyβ drink β his morning fasting blood glucose was paradoxically lower than on evenings when he did not drink. This is a documented pharmacological phenomenon: alcohol inhibits gluconeogenesis in the liver, artificially suppressing fasting glucose readings while the liver is metabolising alcohol.
The reading appeared better. The underlying metabolic situation was not better. If Patrick had not been logging evening readings alongside morning readings β and if his clinical team had not been watching the pattern β this could have been misread as a positive dietary signal.
Patrick identified the correlation, reported it to his clinical team, and verified the mechanism against the published literature on alcohol and gluconeogenesis inhibition. He then removed alcohol from his protocol entirely. His readings stabilised. The data became accurate again.
Patrick stopped immediately. He reported the discovery publicly β because if one person in Ghana is unknowingly misreading their glucose data because of Guinness, there are almost certainly others.
The protocol is supervised. Patrick's nurse contacts him regularly β not when something goes wrong, but proactively, as standard practice. His PA reviews his trends. If a reading is unusual, the response comes before Patrick has had to worry about it. This is what clinical oversight looks like when it is genuinely implemented β not a six-monthly appointment with a ten-minute window, but a continuous relationship with people who are watching your numbers alongside you.
The frequency of monitoring is part of why the protocol works. Most people with Type 2 Diabetes in Ghana have their HbA1c measured every three to six months. Patrick measures his fasting blood glucose every morning. That daily data loop β between patient, readings, and clinical team β creates the feedback mechanism that makes real-time adjustment possible.
What happened
The headline result
Patrick's HbA1c was measured at above 10% at the start of the protocol. At Day 63 β nine weeks into the programme β his HbA1c was 7.2%. A reduction of 2.8 percentage points in 63 days. No medication. No injections. No pharmaceutical intervention of any kind.
The clinical threshold for Type 2 Diabetes remission β as defined by the DiRECT trial and subsequent Diabetes UK and ADA guidance β is an HbA1c below 6.5% without diabetes medication for at least six months. Patrick is approaching that threshold and his trajectory continues downward. His reversal is ongoing.
Reference: Taylor R, et al. Remission of Human Type 2 Diabetes Requires Decrease in Liver and Pancreatic Fat Content but Is Dependent upon Capacity for Ξ² Cell Recovery. Cell Metabolism. DiRECT trial, The Lancet, 2018.
Energy
Patrick describes the pre-protocol version of himself as “barely functioning.” He was exhausted from the moment he woke up. The fog lifted within the first two weeks of fasting. By week four, he was fully operational again β working, building, thinking clearly.
Sleep
Sleep quality transformed alongside glucose readings. The two are connected: high overnight blood glucose disrupts sleep architecture. As his glucose stabilised, his sleep deepened. He now wakes having actually rested.
Vision
Patrick had noticed a gradual degradation in his vision over the preceding two years β a well-documented complication of sustained hyperglycaemia. Within eight weeks of the protocol, he noticed a measurable improvement in visual clarity. An unexpected recovery. A consequence of glucose normalisation that his ophthalmologist confirmed.
Sexual health
Erectile dysfunction is one of the most common and least-discussed complications of uncontrolled Type 2 Diabetes in men β affecting an estimated 50β75% of men with the condition. Patrick chose to report this outcome publicly. It recovered. Fully. Because the underlying cause β hyperglycaemia and the vascular damage it produces β was being addressed directly.
Weight
105 kg to 95 kg. BMI from 35.5 (Obese Class II) to 32.1 (Obese Class I). The weight loss was not the primary goal β the glucose normalisation was. The weight loss followed as a natural consequence of the metabolic correction.
Monthly cost
Patrick was spending approximately GHβ΅ 930 per month on medication, test strips, and laboratory monitoring. His Freedom Protocol membership is GHβ΅ 100/month. The reversal has not cost him more money. It has returned GHβ΅ 830 a month to his household.
βI am not going to pretend this was easy. The first week of fasting was genuinely difficult. The evenings when my family was eating a full meal and I was logging my glucose and drinking water were hard. But here is what I know now: the difficulty of the first week is nothing β nothing β compared to the difficulty of losing your eyesight, or losing sensation in your feet, or not waking up one morning because your glucose was 24 mmol/L and nobody was watching it close enough. I chose the difficulty that leads somewhere. I chose the difficulty that ends.β
The wider context
According to the International Diabetes Federation, there are currently more than 24 million people living with Type 2 Diabetes across Sub-Saharan Africa β a number projected to more than double by 2045. In Greater Accra, the prevalence of diabetes among urban men is estimated at 10.3%. Patrick Dasoberi is not a statistical outlier. He is, in every clinical sense, representative.
The standard of care for Type 2 Diabetes management in Ghana β as in most of Sub-Saharan Africa β is a six-monthly clinic visit, a prescription renewal, and a blood test. The average Ghanaian with Type 2 Diabetes has their HbA1c measured twice a year. That is an 89-day gap between data points during which a person's glucose can be 24 mmol/L and nobody β not the patient, not the doctor β knows about it until it is almost too late.
Freedom Protocol was designed as a structural response to this gap. Not a supplement to existing care. Not a wellness app. A clinical fellowship that makes daily monitoring, continuous clinical supervision, and evidence-based intervention available to Ghanaians at GHβ΅ 100 per month. Less than the cost of a single clinic visit. Available anywhere in Ghana.
Patrick's case is the first documented instance of Freedom Protocol's capacity. It will not be the last.
Africans living with Type 2 Diabetes
IDF Diabetes Atlas, 2023
Expected increase by 2045
Projected by IDF
Prevalence among urban men in Greater Accra
Agyemang et al.
Why the protocol works
Galvus Met works by increasing insulin secretion and reducing hepatic glucose output. It lowers blood glucose. It does not change the underlying insulin resistance. It does not reduce the adipose tissue accumulation in the liver and pancreas that is, according to the current clinical evidence, the primary driver of Type 2 Diabetes pathogenesis. It manages the number. It does not address the cause.
Intermittent fasting combined with caloric restriction and carbohydrate reduction reduces ectopic fat β particularly liver fat and pancreatic fat. The DiRECT trial demonstrated that sustained weight loss of 10β15 kg was sufficient to achieve diabetes remission in a significant proportion of participants. The mechanism is not mysterious: less fat in the liver means less hepatic glucose production. Less fat around the pancreatic beta cells means improved insulin secretion. The numbers fall because the cause of the elevated numbers is being removed.
Patrick's protocol addresses this mechanism directly. The fasting reduces caloric surplus and initiates metabolic switching. The low-carbohydrate diet reduces postprandial glucose spikes and insulin demand. The daily monitoring creates a real-time feedback loop that allows the protocol to be refined continuously. And the clinical supervision ensures that the removal of medication is done safely β with daily readings confirming that the diet is doing what the medication was doing, without the pharmaceutical ceiling that made Patrick's situation so dangerous.
The frequency of contact is not incidental to the outcome. It is a primary reason for it. When Patrick notices an unusual reading, his clinical team sees it within hours, not months. When his protocol needs adjusting, it is adjusted β not at the next appointment, but today. This is what effective metabolic healthcare looks like. It requires continuous presence. Freedom Protocol is built to provide it.
From Patrick
I know what it is like to have a fasting blood glucose of 24 mmol/L and to tell yourself that you are managing. I know what it is like to take tablets every morning and believe that the tablets are enough. I know what it is like to be too tired to change, too overwhelmed to start, too uncertain about whether any of it will actually work.
I also know what it is like to wake up on a morning in April and log a fasting glucose of 6.4 mmol/L and feel β genuinely, bodily feel β that your life has changed. I know what it is like to sleep deeply for the first time in years. To think clearly. To feel present in your own body. To look at a test result and know that the number is going in the right direction and that you are the reason why.
You do not have to have two blackouts first. You do not have to wait until your doctor runs out of prescriptions. You can start now. The protocol is here. The team is here. The evidence is here. What is missing is only your decision.
β Patrick Dasoberi, Founder, Freedom Protocol. April 2026.
Questions answered
The emerging clinical evidence β including the landmark DiRECT trial published in The Lancet β indicates that Type 2 Diabetes can be put into remission through sustained lifestyle intervention, particularly significant caloric restriction and weight loss. Remission is defined as an HbA1c below 6.5% without diabetes medication for at least six months. Patrick Dasoberi achieved an HbA1c of 7.2% in 63 days without medication, and his reversal is ongoing. This outcome does not mean medication is unnecessary or that every person with Type 2 Diabetes can or should stop medication. Any reduction or cessation of diabetes medication must be supervised by a qualified healthcare provider.
The rate of HbA1c reduction depends on the baseline level, the rigour of the intervention, individual metabolic response, and whether medication is removed or maintained. Patrick Dasoberi achieved a 2.8-point reduction in 63 days β from above 10% to 7.2% β through a structured protocol combining intermittent fasting, low-carbohydrate diet adapted for Ghanaian food culture, and daily blood glucose monitoring. Clinical literature suggests that aggressive lifestyle intervention can achieve HbA1c reductions of 1β3 points over three to six months. Results vary significantly between individuals.
Freedom Protocol is a clinically supervised metabolic health fellowship built for Ghana and Africa. Members receive a dedicated Physician Assistant, a dedicated nurse who proactively monitors their readings and contacts them regularly, weekly live group workshops facilitated by health professionals, access to a local and national community, member discounts on laboratory tests and medication, and access to the six-monthly Health Bootcamp. The protocol is built around intermittent fasting, low-carbohydrate diet adapted for local food cultures, daily biomarker monitoring, and structured clinical oversight.
Yes. Every Freedom Protocol member is assigned a dedicated Physician Assistant and a dedicated nurse. All clinical recommendations are reviewed and sanctioned by a licensed physician. Freedom Protocol does not replace your existing doctor β it works alongside your existing healthcare relationships and coordinates with your physician when relevant.
Freedom Protocol is built primarily for people managing metabolic conditions β Type 2 Diabetes, hypertension, obesity, and metabolic syndrome β in Ghana and across Africa. The protocol, the food adaptations, the community, and the clinical team are all designed with the realities of Ghanaian life in mind: the foods available, the economic constraints, the healthcare infrastructure, and the social context.
Patrick followed a structured protocol from Day 1: 16:8 intermittent fasting (eating window 12pmβ8pm), a low-carbohydrate diet adapted entirely to Ghanaian food β no foreign superfoods, no expensive supplements β and daily fasting and evening blood glucose monitoring. He removed Galvus Met 50/1000 from Day 1 and replaced pharmaceutical management with nutritional and metabolic management under clinical oversight. Within 63 days his HbA1c had dropped to 7.2%. Over four months he lost 10 kg. His fasting blood glucose, which had been 24 mmol/L, is now consistently between 6.4 and 7.8 mmol/L.
Begin your own journey
If you are living with Type 2 Diabetes, hypertension, or metabolic syndrome in Ghana β and you are ready to address the cause rather than manage the symptom β Freedom Protocol is ready for you. Choose the level of support that fits your situation.
Clinical management plan
A personalised clinical management plan built around your condition, your readings, and your life. Supervised by a licensed Physician Assistant. Adjusted monthly based on your data. Available anywhere in Ghana.
Apply for clinical planThe Freedom Protocol Fellowship
Everything in the clinical plan, plus a dedicated nurse, weekly live workshops, local community group, emergency hotline, member discounts on labs and medication, and the six-monthly in-person Health Bootcamp. The full fellowship experience.
Learn about the FellowshipBoth pathways require your doctor's involvement. Freedom Protocol works alongside your existing care β not instead of it. pdasoberi@freedomprotocol.health